Zomedica Profit Margin

The latest profit margin for ZOM is -65.78% as of March 2026. That compares with -369.26% in the prior-year period — up 82.2% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Zomedica's historical trend and sector peers before judging valuation or financial health.

Over the past year, ZOM's profit margin moved from -369.26% to -65.78% — a 82.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Zomedica's valuation or profitability profile.

Against Healthcare companies, ZOM currently prints -65.78% for profit margin, while the sector average sits near 15.29%. That is roughly 530.2% below the sector mean. Large gaps often invite a closer look at Zomedica's growth, margins, and balance sheet.

Profit Margin shows how effectively Zomedica converts resources into returns. At -65.78%, ZOM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -369.26% in the prior-year period — up 82.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ZOM's profit margin (-65.78%), review year-over-year change from -369.26%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.